← Open Payments lookup

ERICA KING: Open Payments

NPI 1891376174 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,714 in 86 payments from 34 companies in 2025. Trend: 2023 $47 · 2024 $3,029 · 2025 $2,714

Food & beverage: $1,518Long term medical supply or device loan: $1,097Education: $99
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation18$1,239
Daiichi Sankyo Inc.2$118
Janssen Biotech, Inc.5$116
Takeda Pharmaceuticals U.S.A., Inc.4$96
Celgene Corporation4$75
Alnylam Pharmaceuticals Inc.3$70
Pharmacosmos Therapeutics Inc.3$69
Alexion Pharmaceuticals, Inc.3$62
CSL Behring2$60
Stemline Therapeutics Inc.3$60

Products named: KISQALI, Enhertu, REBLOZYL, FRUZAQLA, GIVLAARI, MONOFERRIC, ULTOMIRIS, Hizentra.

Industry payments across AL — which companies pay providers there.